Partner Courtenay Brinckerhoff is quoted in a Law360 article, “Fed. Circ. Clouds Landscape For Medical Treatment Patents,” about a recent appeals court decision invalidating claims of five Mallinckrodt patents on Inomax, a drug used to treat babies with breathing disorders.
Brinckerhoff said the ruling appears to foreclose patents on such methods of non-treatment, though it’s not clear what could make such claims patentable. “I think most of the Federal Circuit judges believe method-of-treatment claims where you’re actually treating someone are eligible,” she said. “My concern is the slippery slope of that line.”
People
Related News
17 April 2024
In the News
Steven Barth on Allure of Take-Private Deals – 'Public markets aren’t what they’re cracked up to be'
Foley & Lardner LLP partner Steven Barth offers extensive insight on the growing trend of family-owned consumer and retail businesses aiming to go private in the Axios article, “Family-owned companies see allure in take-private deals.”
16 April 2024
In the News
Claire Marblestone Assesses Increased Scrutiny of CA Health Care Transactions
Foley & Lardner LLP partner Claire Marblestone is quoted in the Law360 article, “Struggling Hospitals Seek Mergers As Regulators Push Back.”
15 April 2024
In the News
Nathaniel Lacktman Joins Double Take by Newton Podcast to Talk Telemedicine
Foley & Lardner LLP Nathaniel Lacktman appeared on Newton Investment Management’s Double Take by Newton podcast episode “Modernizing Medicine” to discuss the health care industry’s digital evolution and the benefits of telemedicine.